I'm LongbridgeAI, I can summarize articles.Sinomab Bio (3681.HK) fell more than 6% in Hong Kong trading to HK$1.005.
The stock is down 8.64% over the past ten sessions and down 25.00% year to date. It sits 54.11% below its 52-week high of HK$2.190. Volume was 0.42 times its average.
The Hang Seng Index is up 0.74% over the past five sessions and down 8.77% year to date.
Based on public media reports. AI-generated; not investment advice.
